Dow Up 0.11% Nasdaq Up 0.50%

More On PBMD

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Prima Biomed Ltd. (PBMD)

-NasdaqGM
1.07 Down 0.01(0.93%) Aug 29, 2:14PM EDT
Prev Close:1.08
Open:1.10
Bid:1.05 x 23500
Ask:1.07 x 100
1y Target Est:N/A
Beta:3.18
Next Earnings Date:N/A
Day's Range:1.06 - 1.10
52wk Range:0.82 - 2.45
Volume:9,127
Avg Vol (3m):30,412
Market Cap:43.97M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PBMD

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Prima BioMed Ltd. researches, develops, and commercializes medical biotechnology products in Australia. The company develops immunocellular therapeutic products for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback